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Abstract
Traumatic brain injury (TBI) is a significant cause of disability, but little is known about sex and gender differences after TBI.
We aimed to analyze the association between sex/gender, and the broad range of care pathways, treatment characteristics,
and outcomes following mild and moderate/severe TBI. We performed mixed-effects regression analyses in the prospective
multi-center Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study,
stratified for injury severity and age, and adjusted for baseline characteristics. Outcomes were various care pathway and
treatment variables, and 6-month measures of functional outcome, health-related quality of life (HRQoL), post-concussion
symptoms (PCS), and mental health symptoms. The study included 2862 adults (36% women) with mild (mTBI; Glasgow
Coma Scale [GCS] score 13–15), and 1333 adults (26% women) with moderate/severe TBI (GCS score 3–12). Women were
less likely to be admitted to the intensive care unit (ICU; odds ratios [OR] 0.6, 95% confidence interval [CI]: 0.4-0.8) following
mTBI. Following moderate/severe TBI, women had a shorter median hospital stay (OR 0.7, 95% CI: 0.5-1.0). Following
mTBI, women had poorer outcomes; lower Glasgow Outcome Scale Extended (GOSE; OR 1.4, 95% CI: 1.2-1.6), lower
generic and disease-specific HRQoL, and more severe PCS, depression, and anxiety. Among them, women under age 45 and
above age 65 years showed worse 6-month outcomes compared with men of the same age. Following moderate/severe TBI,
there was no difference in GOSE (OR 0.9, 95% CI: 0.7-1.2), but women reported more severe PCS (OR 1.7, 95% CI: 1.1-2.6).
Men and women differ in care pathways and outcomes following TBI. Women generally report worse 6-month outcomes, but
the size of differences depend on TBI severity and age. Future studies should examine factors that explain these differences.
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Introduction
Traumatic brain injury (TBI) is a major public health con-cern and a leading cause of mortality and disability.1 Many
persons who have experienced a TBI show long-term disturbances
in physical, cognitive, emotional, and overall functioning.1–5
Nevertheless, sex and gender differences in health care and out-
comes after TBI are still insufficiently investigated.
Sex refers to biological characteristics and it can be defined
according to genetics, and morphology, whereas gender refers to
sociocultural behaviors and attitudes. Although the terms are dis-
tinct, ‘‘sex’’ and ‘‘gender’’ are usually used interchangeably in
the field of neurotrauma.6–8 Nevertheless, they highly interact in
humans, and differences in the context of health outcomes in hu-
mans are rarely the product of exclusively sex or gender.9,10 To
emphasize that it is difficult to disentangle biological and socio-
cultural components in TBI, and that sex and gender probably have
a combined impact, we will use the term ‘‘sex/gender’’ to refer to
differences between men and women.
TBI was traditionally considered a ‘‘male problem’’ and asso-
ciated with risk-taking behaviors and male-dominated profes-
sions.7,11 Generally, men have more than a two-fold risk for
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sustaining a TBI and tend to acquire TBIs at a younger age.12
Women, however, catch up in older age with a high proportion
of fall-related TBIs.13,14 In addition, increased participation of
women in the military and contact sports has led to higher TBI
rates among women.1,13,15,16 Moreover, a substantial percentage of
women experience repetitive TBIs as a result of intimate partner
violence.17–20
Current scientific guidelines strongly advise considering sex and
gender in analyzing and reporting outcomes and treatment ef-
fects.21–23 Some studies have shown that women have less access
and lower rates of direct transfers to trauma centers6,24 and fewer
admissions to intensive care25 after traumatic injuries. Following
TBI, adherence to guidelines for performing computed tomogra-
phy (CT) seem to be lower for women.26,27 Further, there is evi-
dence from other medical fields that can potentially be translated
to the field of neurotrauma, such as men being provided with
more aggressive treatments in cardiovascular medicine.28 How-
ever, studies on differences in care specifically for patients with
TBI remain limited, and TBI researchers are encouraged to in-
vestigate sex/gender difference in admission and referral from the
emergency room (ER), and in outcome measures.29
Sex/gender differences in outcomes following TBI have been
investigated more frequently, but often with inconsistent results,29
even for important outcomes such as mortality.6,7,30 Generally,
systematic reviews and syntheses of studies found worse outcomes
in women,8,30,31 particularly following mild TBI (mTBI) and when
cognitive and psychological symptoms after several months were
analyzed as outcomes.8 In the moderate to severe spectrum of TBI,
in which functional outcome and mortality were mostly analyzed as
outcomes, a larger proportion of studies showed similar32,33 out-
comes in men and women, or better outcomes8 in women.
Besides outcome measures and TBI severity, there are other
personal and clinical factors that could impact the results of sex/
gender-based analyses such as extracranial injuries or medical
history, but these are often not included.8,31 For instance, stratified
analyses on both age and sex have shown that certain subgroups are
at higher risk for developing poor outcomes following TBI, such as
young women for post-traumatic stress disorder (PTSD),34 women
in ‘‘child-bearing years’’ for post-concussion symptoms (PCS),35
and older women for mortality after isolated TBI.36
Nevertheless, sex/gender differences in treatment and outcomes
after TBI remain inconclusive. Therefore, the aim of this study
was to determine the association between sex/gender and a broad
range of care pathway and treatment characteristics, and outcomes
following mTBI and moderate/severe TBI.
Methods
Patient population
The study population consisted of patients from the prospective
multi-center longitudinal observational Collaborative European
NeuroTrauma Effectiveness Research in Traumatic Brain Injury
(CENTER-TBI) study.1 For this article, the CENTER-TBI
core data set,37 version 2.0 was used. Data were collected from
December 2014 to December 2017 in 63 European centers and in
accordance with all relevant laws and regulations. Patients were
included if they had a clinical diagnosis of TBI and were presented
to a study center within 24 h of injury either to the ER, admission
ward (ADM), or intensive care unit (ICU); had an indication for
CT scanning; and provided informed consent. Participants were
excluded if they had any severe pre-existing neurological disorder
that could confound outcome assessments.
Participants with a baseline Glasgow Coma Scale (GCS) score
between 13 and 15 were classified as mild, and with a baseline
GCS score between 3 and 12 as moderate/severe. Sex/gender was
defined based on medical records. Sociodemographic variables,
medical history, and clinical and injury characteristics were as-
sessed at admission. CT scanning was performed within 24 h after
injury. The 6-month outcomes were measured 6 months post-injury
(range 5–8 months).
Ethical approval
The CENTER-TBI study (European Commission [EC] grant
602150) has been conducted in accordance with all relevant laws of
the European Union (EU) if directly applicable or of direct effect
and all relevant laws of the country where the recruiting sites were
located, including but not limited to, the relevant privacy and data
protection laws and regulations (the ‘‘Privacy Law’’), the relevant
laws and regulations on the use of human materials, and all relevant
guidance relating to clinical studies from time to time in force
including, but not limited to, the International Conference on
Harmonisation (ICH) Harmonised Tripartite Guideline for Good
Clinical Practice (CPMP/ICH/135/95; ‘‘ICH GCP’’) and the World
Medical Association Declaration of Helsinki entitled ‘‘Ethical
Principles for Medical Research Involving Human Subjects.’’ In-
formed consent by the patients and/or the legal representative/next
of kin was obtained, accordingly to the local legislations, for
all patients recruited in the core data set of CENTER-TBI and
documented in the e-CRF. Ethical approval was obtained for each
recruiting site. The list of sites, ethical committees, approval num-




We analyzed the following care pathway variables:
 Secondary referral: defined as transfer from another hospital
to the study center (vs. primary referral = direct transfer to
the study hospital).
 Time to study center: defined as the time from injury to ar-
rival to study center. It was dichotomized at the group me-
dian and analyzed only for patients with primary referral.
 Discharge home: defined as discharge after the ER versus
discharge to other facility, hospital, high care unit, or ICU
and was analyzed only for patients with mTBI. Admission to
the ICU after the ER versus discharge home, discharge to
other facility, admission to the hospital or a high care unit
was analyzed for all patients and separately for hospitalized
patients with mTBI.
 Discharge to a high care unit or other ICU: versus discharge
to general ward, other hospital, rehabilitation, home, and
nursing home, after being admitted to ICU, and it was ana-
lyzed only for moderate/severe patients.
 Length of stay (LOS): dichotomized at the group median of
hospital stay, and it was analyzed for all patients and for
patients who survived until the discharge.
 Final discharge home: as final discharge location, based on
discharge from the ER, ICU, and hospital (vs. rehabilitation,
nursing home, or other hospital).
 Final discharge to rehabilitation: as final discharge loca-
tion, based on discharge from the ER, ICU, and hospital
(vs. home, nursing home, or other hospital). Final dis-
charge was analyzed for patients who survived until the
discharge.
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As treatment characteristics, we analyzed:
 Pre-hospital intubation: defined as an intubated airway upon
arrival to the study hospital and was analyzed for patients
with moderate/severe TBI.
 Time to CT: defined as time from injury to first CT scanning
and was dichotomized at the group median.
 Intracranial pressure (ICP) monitoring: analyzed only for
patients with moderate/severe TBI.
 Cranial and extra-cranial surgery: performed during stay in
the study hospital.
In-hospital outcome measures
 In-hospital mortality: based on registered death at the ER,
hospital, and ICU discharge.
Functional outcome measures at 6 months
Glasgow Outcome Scale Extended (GOSE). The
GOSE38 is a structured interview that measures global outcome
following TBI. It provides eight ordinal categories of outcome:
dead (1); vegetative state (2); lower severe disability (3); upper
severe disability (4); lower moderate disability (5); upper mod-
erate disability (6); lower good recovery (7); and upper good
recovery (8). GOSE was measured at 6 months by either a postal
questionnaire or a telephone interview. Approximately 7% of
responses were by a proxy alone, and 9% by a patient and proxy
together. The categories ‘‘vegetative state (GOSE 2)’’ and ‘‘lower
severe disability (GOSE 3)’’ were combined, resulting in a 7-point
ordinal scale.
Return to work. Return to work is assessed by a follow-up
questionnaire. Return to work represented post-injury return to
the previous job or school activity at the same or increased level
or hours. Not returning to work represented return to the previous
job or school activity at reduced level, sheltered employment, or
inability to work/go to school. Answers reflecting changing or
searching for a job/school or being retired were not included.
Post-concussion and mental health symptoms
at 6 months
Rivermead Post-Concussion Symptoms Questionnaire
(RPQ). The RPQ39 measures cognitive, somatic, and emotional
symptoms that are compared with the pre-injury level. It contains
16 items that can be answered with 0 = not experienced, 1 = no more
of a problem (than before the injury), 2 = mild problem, 3 = mod-
erate problem, or 4 = severe problem. Total score ‡12 (treating
ratings ‘‘no more of a problem’’ as 0)40 was considered indicative
of having increased PCS.
Patient Health Questionnaire (PHQ-9). The PHQ-941
measures depression severity. It contains nine items using a 4-point
Likert scale (from 0 = not at all to 3 = nearly every day), and it can
have a score range of 0–27. Cutoffs of 5, 10, and 15 indicate mild,
moderate, and moderately severe to severe depressive symptoms,
respectively.42 The score was analyzed as an ordinal variable with
four levels: none, mild, moderate, and moderately severe/severe.
Generalized Anxiety Disorder 7-item scale (GAD-7).
GAD-743 measures severity of anxiety. It comprises seven items
that can be answered from 0 = not at all to 3 = nearly every day, and
it can have a score range of 0–21. Cutoffs 5, 10, and 15 indicate
mild, moderate, and severe anxiety, respectively.43 The score
was analyzed as an ordinal variable with four levels: none, mild,
moderate, and severe.
Post-Traumatic Stress Disorder (PTSD) Checklist for
DSM-5 (PCL-5). 44 PCL-5 measures symptoms of PTSD ac-
cording to DSM-5 criteria.45 It consists of 20 items that can be
answered with 0 = not at all to 5 = extremely, and it can have a score
range of 0–80. A score ‡33 was considered indicative of clinically
relevant PSTD.46,47
Health-related quality of life (HRQoL) measures
at 6 months
Quality of Life after Brain Injury-Overall Scale (QOLIBRI-
OS). The QOLIBRI-OS48 is a brief TBI-specific index of
HRQoL that has a scale range of 0–100. Approximately 3%
of questionnaires were filled by a proxy alone, and 10% by a
patient and proxy together. A score <52 on QOLIBRI-OS
was considered indicative of impaired disease-specific quality
of life.37,49
Short Form Health Surveys (SF-12v2; SF-36v2). SF-12v250
with 12 items and SF-36v2 with 36 items are self-reported
and generic measures of HRQoL. The results can be summa-
rized as mental and physical component scores ranging from 0 to
100. Mental and physical component scores were based on a SF-
12v2 score, and when there was no available SF-12v2 score, the
score was derived using SF-36v2 (when available).37 Approxi-
mately 3% of questionnaires were filled by a proxy alone, and 10%
by a patient and proxy together. Mental and physical component
scores < 40 were considered indicative for impaired mental and
physical HRQoL, respectively.37,49
Statistical analysis
Descriptive statistics. Descriptive statistics for TBI charac-
teristics, and treatment, and outcome variables were presented
separately for men and women using percentages for categorical
variables and median with interquartile range for continuous
outcomes. Differences were tested using non-parametric tests
(e.g., chi-square and Mann-Whitney U test) (Table 1; Supple-
mentary Table S1). All analyses were performed separately for
mTBI and moderate/severe TBI.
Mixed effects regression analyses. The association with
multiple treatment characteristics and outcomes following TBI
was analyzed with univariable and multi-variable mixed effects
regression analyses with a random intercept for study center. In
multi-variable analyses, we adjusted for age, baseline GCS
score, pupillary reactivity, hypotension and hypoxia before ar-
rival/at admission, CT abnormalities (CT Marshall Classifica-
tion), traumatic subarachnoid hemorrhage (tSAH), epidural
hematoma, Injury Severity Score (ISS), pre-injury medical sit-
uation (American Society of Anesthesiologists Physical Status
[ASA PS] Classification), pre-injury psychiatric disorder, and
cause of injury (fall/motor vehicle accident [MVA]/vio-
lence/other), which represent important predictors of outcome in
TBI and/or can be associated with sex/gender.3,46,51–53 Analyses
of pre-hospital and early hospital measures (secondary referral,
time to study center, pre-hospital intubation, time to CT) were
not adjusted for CT Marshall Classification, tSah, and epidural
hematoma.
The multi-variable regression analyses were performed in a
completed data set, in which missing values in potential con-
founders were imputed based on an imputation model with all
baseline characteristics, all outcomes, and auxiliary variables (so-
ciodemographic variables, other indicators of medical history,
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and CT abnormalities). The percentage of imputed missing val-
ues (Table 1) ranged from <1% (age, GCS score, ISS) to 16%
(Marshall CT for moderate/severe). Further, when the out-
come GOSE was assessed outside the time window (range 5–8
months), it was imputed based on GOSE measurements at other
time-points.37 Other outcome variables were not imputed.
Logistic mixed effects regression models were fitted for di-
chotomized outcomes (e.g., treatment variables and mortality),
whereas ordinal mixed effects regression models were fitted for
ordinal outcomes (GOSE, depression and anxiety severity). The
results were presented in forest plots of ORs for women versus
men. For mTBI, forest plots were also stratified by different age
groups: 16–45 years, 45–65 years, and 65 years and older (when
there were ‡100 outcome events in logistic regression). For
moderate/severe TBI, stratified plots were only shown for GOSE
because of smaller subsamples.
To check the sensitivity of the results to imputation of miss-
ing values, and dichotomization of continuous 6-month out-
comes, we performed complete-case and linear regression analyses,
respectively (Supplementary Tables S2 and S3).
Analyses were carried out in R54 (version 5.3) using lme4,55
ordinal,56 mice,57 tableone,58 and forestplot59 packages.
Results
Patient characteristics in men and women
in the CENTER-TBI study
The study included 2862 adults (36% women) categorized as
having mTBI, and 1333 adults (26% women) categorized as having
moderate to severe TBI (Table 1).
Men were younger than women when they suffered a TBI
( p < 0.001). Falls were the most common cause of mTBI for both
men and women, but the proportion of falls was higher in women
( p < 0.001). The most frequent cause of moderate/severe TBI was
an MVA in men and women, but women had more moderate/severe
TBIs due to falls, and men due to violence and other reasons
( p < 0.05). Men with mTBI had higher ISS ( p < 0.001), lower GCS
score ( p < 0.05), and higher percentage of epidural hematoma
( p < 0.001). There were more women who sustained a moderate
TBI, and men who sustained a severe TBI ( p < 0.05). Women had a
higher proportion of psychiatric disorders prior to mTBI and
moderate/severe TBI ( p < 0.001), and worse physical health prior
to mTBI ( p < 0.001; Table 1).
Table 1. Baseline Characteristics of Men and Women with Traumatic Brain Injury in the CENTER-TBI Data
Mild TBI Moderate/severe TBI
Men Women p
Missing
(%) Men Women p
Missing
(%)
N 1842 1020 980 353
GCS baseline (%) 0.04 0 0.01 0
3-8 (%) / / 726 (74.1) 236 (66.9)
9-13 (%) / / 254 (25.9) 117 (33.1)
13 128 (6.9) 63 (6.2) / /
14 340 (18.5) 154 (15.1) / /
15 1374 (74.6) 803 (78.7) / /
Age 50 [32, 65] 58 [37,73] <0.001 0 47 [29, 64] 53 [30,69] 0.02 0
Cause of injury (%) <0.001 1.6 0.01 3.6
Incidental fall 824 (45.7) 570 (56.4) 358 (37.9) 151 (44.3)
MVA 647 (35.8) 330 (32.7) 436 (46.2) 159 (46.6)
Other 173 (9.6) 70 (6.9) 85 (9.0) 17 (5.0)
Violence 161 (8.9) 40 (4.0) 65 (6.9) 14 (4.1)
Total ISS 13 [8, 19] 9.00 [4, 16] <0.00 0.8 34.00 [25, 48] 33.00 [25, 43] 0.28 0.8
Pupils reactivity Baseline (%)a 0.23 4.3 0.44 4.1
Both reactive 1699 (96.9) 964 (98.0) 691 (73.9) 242 (70.3)
One reactive 35 (2.0) 12 (1.2) 77 (8.2) 33 (9.6)
Both non-reactive 20 (1.1) 8 (0.8) 167 (17.9) 69 (20.1)
Hypoxia (%) 42 (2.4) 15 (1.5) 0.17 3.9 164 (17.8) 50 (15.1) 0.29 6.2
Hypotension (%) 47 (2.6) 24 (2.4) 0.84 3.0 159 (17.3) 43 (12.8) 0.07 6.0
Marshall CT Classification (%)a 0.09 9.8 0.36 16.4
No visible pathology 884 (53.3) 531 (57.5) 67 (8.2) 21 (7.1)
Cisterns present 615 (37.1) 321 (34.7) 339 (41.3) 116 (39.5)
Cisterns compressed 23 (1.4) 6 (0.6) 87 (10.6) 32 (10.9)
Midline shift 2 (0.1) 3 (0.3) 22 (2.7) 2 (0.7)
Evacuated and non-evacuated lesion 133 (8.0) 63 (6.8) 305 (37.1) 123 (41.8)
Subarachnoid hemorrhage (%) 524 (30.9) 279 (29.5) 0.46 8.3 652 (76.5) 224 (72.0) 0.13 13.2
Epidural hematoma (%) 159 (9.4) 46 (4.9) <0.00 7.9 144 (16.9) 51 (16.4) 0.91 13.0
Pre-injury psychiatric condition (%) 210 (11.6) 183 (18.0) <0.00 1.0 120 (13.3) 64 (19.1) 0.01 7.1
Pre-injury physical health - ASA PS Classification (%) 0.23 1.0 0.23 5.6
Healthy patients 1063 (58.5) 505 (49.8) 532 (57.5) 177 (53.2)
Mild systemic disease 567 (31.2) 388 (38.2) 283 (30.6) 122 (36.6)
Severe systemic disease/threat to life 188 (10.4) 122 (12.0) 110 (11.9) 34 (10.2)
aSmall subcategories merged for regression analyses.
ASA PS, American Society of Anesthesiologists Physical Status; CT, computed tomography; GCS, Glasgow Coma Scale; ISS, Injury Severity Score;
MVA, motor vehicle accident; TBI, traumatic brain injury.
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Table 2. Descriptive Statistics for Care Pathway and Treatment Characteristics
for Men and Women with Traumatic Brain Injury
Mild TBI Moderate/severe TBI
Men Women p Men Women p
N 1842 1020 980 353
Secondary referral (%) 287 (15.6) 120 (11.8) 0.006 189 (19.3) 67 (19.0) 0.963
Discharge home (%) 459 (25.0) 343 (33.9) <0.001
ICU admission (%) 428 (23.3) 146 (14.4) <0.001 687 (70.6) 233 (66.6) 0.181
Discharge to high care (%) 189 (25.4) 69 (24.8) 0.921
Longer LOS (median) (%) 949 (52.4) 460 (46.0) 0.001 495 (52.2) 150 (44.0) 0.012
Longer LOS (median) (%), survivors 412 (43.4) 117 (34.3) 0.004
Final discharge location (%), survivors 0.077 0.987
Home 1410 (80.1) 797 (82.1) 0.220 182 (25.2) 63 (24.2) 0.811
Rehabilitation 109 (6.2) 58 (6.0) 0.887 240 (33.3) 88 (33.8) 0.931
Pre-hospital intubation (%) 561 (58.0) 180 (51.4) 0.039
Longer time to CT (median) (%) 823 (48.2) 509 (53.4) 0.012 438 (50.8) 152 (48.9) 0.616
ICP monitoring (%) 539 (58.5) 180 (54.9) 0.288
Cranial surgery (%) 163 (11.6) 63 (9.3) 0.135 428 (44.0) 150 (43.2) 0.844
Extra-cranial surgery (%) 218 (15.6) 87 (12.9) 0.123 288 (29.6) 86 (24.8) 0.099
CT, computed tomography; ICP, intracranial pressure; ICU, intensive care unit; LOS, length of stay.
FIG. 1. Forest plot with adjusted odds ratios (ORs) for women with mild traumatic brain injury: care pathway and treatment
characteristics. The ORs are adjusted for age, baseline Glasgow Coma Scale score, pupillary reactivity, hypotension and hypoxia before
arrival/at admission, Marshall Classification, traumatic subarachnoid hemorrhage (tSAH), epidural hematoma; Injury Severity Score
(ISS), pre-injury medical situation (ASA PS Classification), pre-injury psychiatric disorder, and cause of injury. *Not adjusted for CT
Marshall Classification, tSAH, and epidural hematoma. ASA PS, American Society of Anesthesiologists Physical Status; CT, computed
tomography; ICU, intensive care unit; n/outcome, number of patients/number of patients with outcome.
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The association between sex/gender
and care pathway and treatment characteristics
Following mTBI, women had different care pathways, with a
lower proportion of referrals from another hospital (12% vs. 16%)
and admissions to the ICU (14% vs. 23%), more discharge home
(34% vs. 25%), and shorter hospital stay (46% vs. 52% higher than
median stay). Regarding treatment characteristics, women had
longer time to CT scan (53% vs. 48% higher than median; Table 2;
Supplementary Fig. S1).
Following moderate/severe TBI, men and women had similar
care pathway and treatment characteristics. Women, however, had
shorter hospital stays (44% vs. 52% for all, 34% vs. 43% above
the median of LOS), and had fewer pre-hospital intubations (51%
vs. 58%, Table 2; Supplementary Fig. S2).
In mixed-effect multi-variable analyses (Fig. 1), there were
no significant differences between men and women with mTBI
in the majority of care pathway and treatment characteristics.
Women who sustained an mTBI were less likely to have a
secondary referral (odds ratio [OR] 0.7, 95% confidence interval
[CI]: 0.6-0.95). Moreover, women were more likely to be dis-
charged home after presenting to the ER (OR 1.4, 95% CI: 1.0-
1.8); and less likely to be admitted to the ICU (OR 0.6, 95% CI:
0.4-0.8), in the total mTBI sample and among hospitalized
mTBI patients.
Men and women with moderate or severe TBI did not differ in
the majority of care pathway and treatment characteristics (Fig. 2).
Among patients with primary referral (direct transfer to study
hospital), women were somewhat less likely to have longer time to
study hospital (OR 0.8, 95% CI: 0.6-1.1). Further, women were
more likely to have a rehabilitation as the final discharge location
(OR 1.5, 95% CI: 1.0-2.1), but less likely to stay in the hospital
longer than a median of 22 days (patients who survived until dis-
charge; OR 0.7, 95% CI: 0.5-1.0), and to have pre-hospital intu-
bation (OR 0.8, 95% CI: 0.6-1.1).
The association between sex/gender, and in-hospital
mortality and 6-month outcomes
For mTBI, the proportion of missing values in 6-month out-
comes varied from 17% for GOSE to 40–45% for other outcomes.
For moderate or severe TBI, the proportion of missing values
varied from 1% for in-hospital mortality, 13% for GOSE, to about
60% for other outcomes (Supplementary Table S1). However,
26% of patients with moderate/severe TBI did not survive until 6
months.
Following mTBI, women had a higher percentage of unfavorable
outcomes (lower GOSE), lower generic and disease-specific
HRQoL, and more severe PCS, depression, anxiety, and PTSD
FIG. 2. Forest plot with adjusted odds ratios (ORs) for women with moderate/severe traumatic brain injury: care pathway and
treatment characteristics. The ORs are adjusted for age, baseline Glasgow Coma Scale score, pupillary reactivity, hypotension and
hypoxia before arrival/at admission, Marshall Classification, traumatic subarachnoid hemorrhage (tSAH), epidural hematoma, Injury
Severity Score (ISS), pre-injury medical situation (ASA PS Classification), pre-injury psychiatric disorder, and cause of injury. ASA PS,
American Society of Anesthesiologists Physical Status; CT, computed tomography; ICP, intracranial pressure; ICU, intensive care unit;
n/outcome, number of patients/number of patients with outcome.
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(Table 3; Supplementary Table S1; Supplementary Fig. S3). There
was no difference in probable PTSD diagnosis. Following moder-
ate/severe TBI, women had more severe PCS (Table 3; Supple-
mentary Table S1; Supplementary Fig. S4). Mental health measures
were somewhat poorer in men, but the differences were insignificant
(Table 3; Supplementary Table S1, Supplementary Fig. S4).
In multi-variable analyses of patients with mTBI (Fig. 3), women
were more likely to have a poor global outcome (OR 1.4, 95% CI:
1.2-1.6 for ordinal GOSE), and not to return to work (OR 1.4, 95%
CI: 1.0-1.9). Moreover, women were more likely to experience more
severe PCS (OR 1.7, 95% CI: 1.3-2.1), depression (OR 1.6, 95% CI:
1.3-2.0), anxiety (OR 1.6, 95% CI: 1.2-2.0), and to report impaired
disease-specific (OR 1.8, 95% CI: 1.4-2.3), mental (OR 1.6, 95% CI:
1.3-2.1) and physical (OR 1.8, 95% CI: 1.4-2.3) generic HRQoL.
There was no association between sex/gender and probable PTSD
diagnosis (OR 1.1, 95% CI: 0.7-1.6) present in smaller percentage of
patients, but women showed higher PTSD symptoms in linear
analysis (beta = 1.88, p = 0.01; Supplementary Table S3).
Following moderate or severe TBI, multi-variable analyses
(Fig. 4) showed somewhat lower, but insignificant, ORs for women
for in-hospital mortality (OR 0.8, 95% CI: 0.5-1.2) and mortality at
6 months (OR 0.7, 95% CI: 0.5-1.0). No (substantial) differences
were found in 6-month ordinal GOSE (OR 0.9, 95% CI: 0.7-1.2),
return to work (OR 1.2, 95% CI: 0.7-2.1), or impaired physical
HRQoL (OR 1.2, 95% CI: 0.7-1.2). Adjusted linear analyses
showed no differences in brain-injury-specific and physical
HRQoL (Supplementary Table S3).
However, women were more likely to experience more severe
PCS (OR 1.7, 95% CI: 1.1-3.0). The likelihood for depression se-
verity (OR 1.3, 95% CI: 0.9-1.9), anxiety severity (OR 1.3, 95% CI:
0.9-2.0), probable PTSD diagnosis (OR 1.5, 95% CI: 0.7-3.3),
impaired mental (OR 1.4, 95% CI: 0.9-2.2) and impaired disease-
specific HRQoL (OR 1.4, 95% CI: 0.9-2.1) assessed with the
QOLIBRI-OS was somewhat higher in women, but precision was
limited and CIs included the null.
The association between sex/gender and 6-month
outcomes in different age groups
Sex/gender differences in different age groups of mTBI patients
varied between outcomes (Fig. 5; Supplementary Fig. S5). There
was, however, no outcome or age group where men had worse
Table 3. Distributions of Outcome Variables for Men and Women with Mild and Moderate
or Severe Traumatic Brain Injury
Mild TBI Moderate/severe TBI
Men Women p Men Women p
N 1842 1020 980 353
In-hospital mortality (%) 28 (2.0) 15 (2.2) 0.863 213 (22.0) 73 (20.9) 0.717
Functional outcomes at 6 months
GOSE (%) 0.005 0.464
1 56 (3.7) 33 (3.9) 258 (30.6) 89 (28.3)
3 59 (3.9) 37 (4.3) 148 (17.5) 53 (16.8)
4 43 (2.8) 40 (4.7) 53 (6.3) 29 (9.2)
5 110 (7.2) 61 (7.1) 113 (13.4) 43 (13.7)
6 158 (10.4) 90 (10.5) 98 (11.6) 29 (9.2)
7 310 (20.4) 218 (25.5) 80 (9.5) 37 (11.7)
8 783 (51.5) 376 (44.0) 94 (11.1) 35 (11.1)
Return to work (%) <0.001 0.005
Job change 48 (4.3) 26 (4.2) 26 (5.4) 5 (2.9)
Not returned 203 (18.1) 110 (17.8) 295 (61.7) 96 (55.5)
Retired 260 (23.2) 206 (33.3) 52 (10.9) 37 (21.4)
Returned 610 (54.4) 277 (44.7) 105 (22.0) 35 (20.2)
Post-concussion and mental health symptoms at 6 months
Post-concussion (RPQ >11) (%) 320 (31.4) 246 (41.9) <0.001 154 (43.3) 83 (56.5) 0.009
Depression (PHQ-9) (%) <0.001 0.599
None 637 (64.1) 302 (52.7) 188 (53.6) 69 (47.6)
Mild 213 (21.4) 151 (26.4) 91 (25.9) 40 (27.6)
Moderate 85 (8.6) 73 (12.7) 43 (12.3) 20 (13.8)
Severe 59 (5.9) 47 (8.2) 29 (8.3) 16 (11.0)
Anxiety, GAD-7 (%) 0.001 0.513
None 734 (74.0) 368 (64.7) 244 (68.9) 91 (63.2)
Mild 168 (16.9) 125 (22.0) 67 (18.9) 31 (21.5)
Moderate 58 (5.8) 48 (8.4) 25 (7.1) 15 (10.4)
Severe 32 (3.2) 28 (4.9) 18 (5.1) 7 (4.9)
PTSD - PCL-5 > 32 (%) 96 (9.6) 57 (9.9) 0.926 30 (8.8) 14 (9.6) 0.930
Health-related quality of life (HRQoL) at 6 months
QOLIBRI - OS <52 (%) 175 (16.9) 158 (26.6) <0.001 103 (27.5) 51 (33.1) 0.232
SF12 mental score <40 (%) 211 (20.3) 177 (29.5) <0.001 92 (25.3) 48 (31.4) 0.188
SF12 physical score <40 (%) 235 (22.6) 206 (34.3) <0.001 129 (35.4) 59 (38.6) 0.566
GAD-7, Generalized Anxiety Disorder 7-item scale; GOSE, Glasgow Outcome Scale Extended; PCL-5, Post-Traumatic Stress Disorder Checklist for
DSM-5; PHQ-9, Patient Health Questionnaire 9-item; QOLIBRI-OS, Quality of Life after Brain Injury-Overall Scale; RPQ, Rivermead Post-Concussion
Symptoms Questionnaire; SF12, Short Form Health Survey 12 item; TBI, traumatic brain injury.
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outcomes, only the lack of differences or worse functioning of
women were observed. The biggest sex/gender difference for
GOSE (OR 1.9, 95% CI: 1.4-2.5), not returning to work (OR 1.6,
95% CI: 0.9-2.8), and PCS (OR 2.5, 95% CI: 1.5-3.8) were found in
patients younger than age 45 years.
The difference was most pronounced in patients younger
than age 45 years and older than 65 years for mental health and
HRQoL: depression (OR 2.2, 95% CI: 1.5-3.2; OR 2.1, 95% CI:
1.3-3.2, respectively); anxiety (OR 1.9, 95% CI: 1.3-2.9; OR 1.7,
95% CI: 1.0-2.7), impaired mental (OR 2.4, 95% CI: 1.5-3.8; OR
2.0, 95% CI: 1.2-3.4), physical (OR 1.9, 95% CI: 1.1-3.3; OR 2.3,
95% CI: 1.5-3.5), and disease-specific HRQoL (OR 2.2, 95% CI:
1.3-3.6; OR 2.3, 95% CI: 1.3-3.8).
Following moderate/severe TBI (Fig. 6; Supplementary Fig. S6),
women over age 65 years had a lower likelihood of poor functional
outcome (GOSE) than men (OR 0.6, 95% CI: 0.3-0.96), whereas
women under age 65 years had similar (or slightly worse) global
functioning as men (OR 1.2, 95% CI: 0.8-1.7) under 45 years;
(OR 1.0, 95% CI: 0.6-1.5; 45–65).
Discussion
We examined sex/gender differences in various care pathway
and treatment characteristics and outcomes following mTBI and
moderate/ severe TBI. Men and women did not substantially differ
in treatment characteristics, but some differences in care pathway,
particularly discharge destinations following mTBI, were found.
Women generally reported worse 6-month outcomes, but the dif-
ferences with men depended on TBI severity and age. Sex/gender
differences were more pronounced following mTBI, particularly
under 45 and above 65 years of age.
We did not find strong association between sex/gender and most
of the care pathway and treatment variables. Following mTBI,
women were less likely to be referred from another hospital to a
study center, and to be admitted to the ICU, and were more likely
to be discharged home. Apart from that, some differences were
observed with limited precision: men had a longer hospital stay and
less discharge to rehabilitation following moderate/severe TBI.
Similar studies are limited in the field of TBI, and observed dif-
ferences are partially consistent with other studies in trauma and
critical care.
Contrary to our results of women’s more direct transfers and
thus decreased time to study center, some previous studies have
identified less access for women in general trauma care.6,60 For
example, in a large Canadian retrospective cohort study, women
had a lower likelihood of direct transfer to trauma centers by both
emergency service triage and the physicians.24 Consistent with
our result of fewer ICU admissions following mTBI (but not
moderate/severe), some other studies have found less access to
intensive care after traumatic injuries in women.25,61–64 Similarly,
FIG. 3. Forest plot with adjusted odds ratios (ORs) for women with mild traumatic brain injury: 6-month outcomes. The ORs are
adjusted for age, baseline Glasgow Coma Scale score, pupillary reactivity, hypotension and hypoxia before arrival/at admission,
Marshall Classification, traumatic subarachnoid hemorrhage (tSAH), epidural hematoma, Injury Severity Score (ISS), pre-injury
medical situation (ASA PS Classification), pre-injury psychiatric disorder, and cause of injury. ASA PS, American Society of An-
esthesiologists Physical Status; GOSE, Glasgow Outcome Scale Extended; PTSD, post-traumatic stress disorder; n/outcome, number of
patients/number of patients with outcome.
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women are shown to receive fewer aggressive treatments in other
medical fields.28,65
Lower rates of intensive care in women, as well as their shorter
hospital stay, are usually attributed to women’s lower injury se-
verity, different injury mechanisms, and better recovery.25,33,61
Even though we adjusted for baseline characteristics in our ana-
lyses, residual confounding remains possible. Therefore, the ob-
served differences can be also the result of insufficient adjustment
for differences in clinical needs.64,65 Nevertheless, obtaining
differences in trauma care pathway after adjustment for relevant
variables cannot completely rule out gender bias as a possible
explanation.30,62,66,67 For better insight in patterns of care path-
ways, more studies on sex/gender differences in health care are
necessary in the field of neurotrauma. In any case, discussing the
importance of gender in context of health, and potential bias
related to gender (and other aspects of identity) should be uni-
versally and systematically incorporated in training of health care
providers.
The study results are in line with some previous findings of
worse outcomes in women several months after injury.8,30 Women
reported more severe mental health and post-concussion symp-
toms compared with men, particularly following mTBI, where
women reported worse outcomes across all domains. Differences
following moderate/severe TBI were generally smaller and less
precise. The differences in self-report, particularly in the mental
domain, might not be specifically related to the experience of
TBI. Women generally tend to self-report more symptoms, and to
seek medical help when needed.68–70 Mental health disturbances
from the depressive and anxiety spectrum are generally higher in
women than men, particularly in the young age.71–74
In addition, biological factors can interact with the general
gender differences and contribute to more symptoms in women. For
instance, disruption in hypothalamic-pituitary axis (HPA) and hy-
popituitarism seem to occur in more than one-quarter of patients
after TBI, and even in 15% of patients with complicated mTBI,75
which may affect outcomes and stress levels in a sex-specific
manner. A recent study found differential dysregulation of HPA
and, consequently, stress response, following mTBI in female
compared with male mice.76
Conversely, a neuroprotective role of the hormones estrogen and
progesterone after TBI was found in animal studies and speculated
in human studies, but the findings in human studies have been
mixed.8,77,78 Thus, differences in mortality after TBI were incon-
sistent in previous studies,6,7,30,79 and they stayed unclear in our
study with an insignificant lower likelihood of dying in the hospi-
tal or by 6 months for women. Further, we found a pattern of
more disadvantage of women (vs. men) in global functioning in
reproductive age than other age groups, which is not in line with
explanations based on neuroprotection of sex steroids.78 Some
authors explain this pattern by post-TBI disruption in production
of sex steroids in pre-menopausal women, which results in the
reduction of the neuroprotection.35,80
FIG. 4. Forest plot with adjusted odds ratios (ORs) for women with moderate/severe traumatic brain injury: in-hospital mortality and
6-month outcomes. The ORs are adjusted for age, baseline Glasgow Coma Scale score, pupillary reactivity, hypotension and hypoxia
before arrival/at admission, Marshall Classification, traumatic subarachnoid hemorrhage (tSAH), epidural hematoma, Injury Severity
Score (ISS), pre-injury medical situation (ASA PS Classification), pre-injury psychiatric disorder, and cause of injury. ASA PS,
American Society of Anesthesiologists Physical Status; GOSE, Glasgow Outcome Scale Extended; PTSD, post-traumatic stress dis-
order; n/outcome, number of patients/number of patients with outcome.
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In this study, women under 45 years of age, and over 65 years for
some outcomes, showed particularly worse 6-month outcomes
following mTBI compared with men of the same age. Besides
hormonal differences, men and women under age 45 years may
face different challenges in everyday life. Women report struggling
with expectations of managing the household, and balancing do-
mestic duties and childcare with rehabilitation when recovering
from acquired brain injury.81,82 A substantial number of young
adult women have to combine the role of the primary caregiver of
underage children with the work role. In that way, gender norms
can create an extra burden for women under age 45 years, and
negatively impact their quality of life and mental health following
TBI.35,83 In contrast, men may have the pressure to return to work
and normal functioning more quickly, because they still prevail
as primary wage earners,35,83 which could lead to better global
functional outcome. At older age, women tend to outlive their
partners, and they are more likely to live alone following TBI.84 In
addition, generally lower economic resources and power in the
society can reduce (older) women’s ability to adequately cope with
a condition such as brain injury.7,70,85,86
Sex/gender differences in subjective measures were, however,
more pronounced in the mild versus moderate/severe TBI group.
Difference in functioning following moderate or severe injuries
may be more closely related to injury-related, physical and neu-
rological disabilities.3,43 In contrast, functioning after milder in-
juries may be under a greater influence of differences in self-report,
perceived stress, and socioeconomic factors, which are associated
with sex and gender. Thus, taking sex/gender into account could be
particularly beneficial in scheduling follow-up appointments and
organizing rehabilitation following mTBI. Further, treatment dif-
ferences could also impact outcomes after several months. For
instance, direct transfer and short time to trauma care generally
contribute to better outcomes. The potential impact of the admis-
sion to the ICU after mTBI is unclear. A substantial proportion of
ICU admissions following mTBIs seem to be unnecessary87 and
admission can be associated with negative psychological conse-
quences,88 but some patients do benefit from intensive monitoring.
This study has some limitations. First, the proportion of missing
values was high for some 6-month outcomes, particularly in the
moderate/severe group. Men had larger proportions of missing
values in 6-month mental health and quality-of-life outcomes;
however, the proportions were comparable between men and wo-
men who survived until 6 months. Further, due to testing for
multiple end-points, which can increase the probability of false-
positive findings, it is possible that some differences were found
due to chance. On the other hand, analyses of patients with
moderate/severe TBI and age groups could be underpowered to
find sex/gender differences. Moreover, although we adjusted the
FIG. 5. Forest plot with adjusted odds ratios (ORs) for women in different age groups: outcomes following mild traumatic brain
injury. The ORs are adjusted for age, baseline Glasgow Coma Scale score, pupillary reactivity, hypotension and hypoxia before
arrival/at admission, Marshall Classification, traumatic subarachnoid hemorrhage (tSAH), epidural hematoma, Injury Severity Score
(ISS), pre-injury medical situation (ASA PS Classification), pre-injury psychiatric disorder, and cause of injury. ASA PS, American
Society of Anesthesiologists Physical Status; GOSE, Glasgow Outcome Scale Extended ;n/outcome, number of patients/number of
patients with outcome.
244 MIKOLIĆ ET AL.
analyses with numerous relevant variables, we might have missed
some important confounders for specific analyses. Additionally,
sex was based on medical records and therefore may be incorrect
for some patients, or not correctly matched to the gender identity
(being a woman or a man). We recognize that there is a notable
minority of both intersex and cisgender persons, who were not
adequately captured by this dichotomy. Future TBI studies could
profit from including more detailed measures of gender.
Further, this study included hospital centers across Europe
(and Israel), with the majority being academic hospitals located in
urban areas in West and North Europe.37,89 Between and within
European countries, there is variability in health care and care
pathways following TBI,37,90 but also in gender equality in access
to health care and unmet medical needs.91 Generally, areas with
more traditional and restrictive gender norms, and with less im-
plemented strategies to reduce gender bias in health systems, tend
to have larger gender inequalities in health care.92,93 Following
TBI, we hypothesize that in those areas men are offered more
aggressive treatments, and women have less access to care, par-
ticularly in case of violence. In addition, differences in intention
to self-report symptoms following TBI may be greater in the
context of more traditional gender norms.94 A reliable sex/gender
analyses stratified by country or region would require a higher
sample and better representation of East and South Europe, and
smaller hospital centers. Moreover, the ability to generalize the
findings of a European study to other geopolitical and cultural
settings is limited.
A strength of the study is the use of a large data set of repre-
sentative contemporary patients from different countries and with
different injury severity. Importantly, there is a lack of studies on
treatment and care pathway in the context of sex/gender and TBI,
and this study provides an overview of a range of important char-
acteristics. For 6-month functioning, a broad battery of different
outcomes was used to cover various domains. The analyses were
adjusted for study center and important personal and injury char-
acteristics, which was a limitation of many previous studies.
In conclusion, men and women differ in care pathway and out-
comes, depending on injury severity and age group. Future studies
should continue investigating sex and gender differences in health
care after TBI. In addition, underlying factors of the differences
in outcomes, particularly following mTBI, should be explored
by disentangling the influence of socioeconomic, biological, and
treatment differences. Finally, differences should also be discussed
in the context of provision and organization of care, such as in-
corporating gender considerations into the training of health care
providers, and monitoring and rehabilitation of patients at risk for
poorer outcomes following TBI.
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IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy;
Maria Rosa Calvi, S. Raffaele University Hospital, Milan, Italy;
Peter Cameron, Monash University, Melbourne, Victoria, Aus-
tralia; Guillermo Carbayo Lozano, Hospital of Cruces, Bilbao,
Spain; Marco Carbonara, Fondazione IRCCS Cà Granda Ospedale
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Amra Čović, Universitätsmedizin Göttingen, Göttingen, Germany;
Nicola Curry, Oxford University Hospitals NHS Trust, Oxford,
UK; Endre Czeiter, University of Pécs, Hungary; Marek Czosnyka,
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